Literature DB >> 16896111

Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis.

Edward J Mills1, Jean B Nachega, Iain Buchan, James Orbinski, Amir Attaran, Sonal Singh, Beth Rachlis, Ping Wu, Curtis Cooper, Lehana Thabane, Kumanan Wilson, Gordon H Guyatt, David R Bangsberg.   

Abstract

CONTEXT: Adherence to antiretroviral therapy is a powerful predictor of survival for individuals living with human immunodeficiency virus (HIV) and AIDS. Concerns about incomplete adherence among patients living in poverty have been an important consideration in expanding the access to antiretroviral therapy in sub-Saharan Africa.
OBJECTIVE: To evaluate estimates of antiretroviral therapy adherence in sub-Saharan Africa and North America. DATA SOURCES: Eleven electronic databases were searched along with major conference abstract databases (inclusion dates: inception of database up until April 18, 2006) for all English-language articles and abstracts; and researchers and treatment advocacy groups were contacted. Study Selection and Data Abstraction To best reflect the general population, studies of mixed populations in both North America and Africa were selected. Studies evaluating specific populations such as men only, homeless individuals, or drug users, were excluded. The data were abstracted in duplicate on study adherence outcomes, thresholds used to determine adherence, and characteristics of the populations. A random-effects meta-analysis was performed in which heterogeneity was examined using multivariable random-effects logistic regression. A sensitivity analysis was performed using Bayesian methods. DATA SYNTHESIS: Thirty-one studies from North America (28 full-text articles and 3 abstracts) and 27 studies (9 full-text articles and 18 abstracts) from sub-Saharan Africa were included. African studies represented 12 sub-Saharan countries. Of the North American studies, 71% used patient self-report to assess adherence; this was true of 66% of the African assessments. Studies reported similar thresholds for adherence monitoring (eg, 100%, >95%, >90%, >80%). A pooled analysis of the North American studies (17,573 patients total) indicated a pooled estimate of 55% (95% confidence interval, 49%-62%; I2, 98.6%) of the populations achieving adequate levels of adherence. Our pooled analysis of African studies (12,116 patients total) indicated a pooled estimate of 77% (95% confidence interval, 68%-85%; I2, 98.4%). Study continent, adherence thresholds, and study quality were significant predictors of heterogeneity. Bayesian analysis was used as an alternative statistical method for combining adherence rates and provided similar findings.
CONCLUSION: Our findings indicate that favorable levels of adherence, much of which was assessed via patient self-report, can be achieved in sub-Saharan African settings and that adherence remains a concern in North America.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16896111     DOI: 10.1001/jama.296.6.679

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  373 in total

1.  Viremia and drug resistance among HIV-1 patients on antiretroviral treatment: a cross-sectional study in Soweto, South Africa.

Authors:  Ziad El-Khatib; Anna Mia Ekstrom; Johanna Ledwaba; Lerato Mohapi; Fatima Laher; Alan Karstaedt; Salome Charalambous; Max Petzold; David Katzenstein; Lynn Morris
Journal:  AIDS       Date:  2010-07-17       Impact factor: 4.177

2.  Challenges in using mobile phones for collection of antiretroviral therapy adherence data in a resource-limited setting.

Authors:  Jessica E Haberer; Julius Kiwanuka; Denis Nansera; Ira B Wilson; David R Bangsberg
Journal:  AIDS Behav       Date:  2010-12

3.  Suboptimal adherence associated with virological failure and resistance mutations to first-line highly active antiretroviral therapy (HAART) in Bangalore, India.

Authors:  Maria L Ekstrand; Anita Shet; Sara Chandy; Girija Singh; Ranjani Shamsundar; Vidya Madhavan; Shanmugam Saravanan; Elsa Heylen; Nagalingeswaran Kumarasamy
Journal:  Int Health       Date:  2011-03       Impact factor: 2.473

Review 4.  Primary drug resistance in South Africa: data from 10 years of surveys.

Authors:  Justen Manasa; David Katzenstein; Sharon Cassol; Marie-Louise Newell; Tulio de Oliveira
Journal:  AIDS Res Hum Retroviruses       Date:  2012-03-12       Impact factor: 2.205

Review 5.  Antiretroviral therapy and program retention in urban slums.

Authors:  Brodie Ramin; Kevin Pottie
Journal:  J Urban Health       Date:  2013-02       Impact factor: 3.671

6.  Randomized controlled trial of trained patient-nominated treatment supporters providing partial directly observed antiretroviral therapy.

Authors:  Jean B Nachega; Richard E Chaisson; Rene Goliath; Anne Efron; Mohammad A Chaudhary; Malathi Ram; Chelsea Morroni; Hennie Schoeman; Amy R Knowlton; Gary Maartens
Journal:  AIDS       Date:  2010-06-01       Impact factor: 4.177

7.  90-90-90-Plus: Maintaining Adherence to Antiretroviral Therapies.

Authors:  Inge B Corless; Alex J Hoyt; Lynda Tyer-Viola; Elizabeth Sefcik; Jeanne Kemppainen; William L Holzemer; Lucille Sanzero Eller; Kathleen Nokes; J Craig Phillips; Carol Dawson-Rose; Marta Rivero-Mendez; Scholastika Iipinge; Puangtip Chaiphibalsarisdi; Carmen J Portillo; Wei-Ti Chen; Allison R Webel; John Brion; Mallory O Johnson; Joachim Voss; Mary Jane Hamilton; Kathleen M Sullivan; Kenn M Kirksey; Patrice K Nicholas
Journal:  AIDS Patient Care STDS       Date:  2017-05       Impact factor: 5.078

8.  Psychiatric disorders and adherence to antiretroviral therapy among a population of HIV-infected adults in Nigeria.

Authors:  Olurotimi Adejumo; Bibilola Oladeji; Onoja Akpa; Kay Malee; Olusegun Baiyewu; Adesola Ogunniyi; Scott Evans; Baiba Berzins; Babafemi Taiwo
Journal:  Int J STD AIDS       Date:  2015-09-18       Impact factor: 1.359

9.  The role of mental health in mediating the relationship between social support and optimal ART adherence.

Authors:  Alexis K Huynh; Janni J Kinsler; William E Cunningham; Jennifer N Sayles
Journal:  AIDS Care       Date:  2013-01-15

10.  Reduced adherence to antiretroviral therapy among HIV-infected Tanzanians seeking cure from the Loliondo healer.

Authors:  Nathan M Thielman; Jan Ostermann; Kathryn Whetten; Rachel Whetten; Dafrosa Itemba; Venance Maro; Brian Pence; Elizabeth Reddy
Journal:  J Acquir Immune Defic Syndr       Date:  2014-03-01       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.